Pacer Advisors Inc. Buys 180 Shares of Exponent, Inc. (NASDAQ:EXPO)

Pacer Advisors Inc. grew its stake in Exponent, Inc. (NASDAQ:EXPO) by 2.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,574 shares of the business services provider’s stock after purchasing an additional 180 shares during the period. Pacer Advisors Inc.’s holdings in Exponent were worth $675,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of the stock. Barclays PLC boosted its holdings in shares of Exponent by 219.0% in the 3rd quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock worth $11,127,000 after acquiring an additional 66,263 shares in the last quarter. Geneva Capital Management LLC lifted its holdings in Exponent by 1.7% during the 3rd quarter. Geneva Capital Management LLC now owns 1,590,804 shares of the business services provider’s stock worth $183,388,000 after buying an additional 27,339 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Exponent by 63.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock worth $72,701,000 after buying an additional 245,086 shares in the last quarter. Argent Capital Management LLC raised its position in shares of Exponent by 17.3% during the 4th quarter. Argent Capital Management LLC now owns 28,323 shares of the business services provider’s stock valued at $2,524,000 after acquiring an additional 4,173 shares during the last quarter. Finally, Citigroup Inc. raised its position in shares of Exponent by 174.7% during the 3rd quarter. Citigroup Inc. now owns 48,309 shares of the business services provider’s stock valued at $5,569,000 after acquiring an additional 30,723 shares during the last quarter. 92.37% of the stock is currently owned by institutional investors.

Exponent Stock Performance

Shares of Exponent stock opened at $91.79 on Tuesday. The firm has a fifty day moving average of $92.56 and a two-hundred day moving average of $101.05. The stock has a market capitalization of $4.66 billion, a price-to-earnings ratio of 44.34 and a beta of 0.71. Exponent, Inc. has a 52 week low of $74.30 and a 52 week high of $115.75.

Insider Buying and Selling at Exponent

In related news, Director Paul R. Johnston sold 14,000 shares of the company’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total value of $1,464,400.00. Following the completion of the sale, the director now owns 80,742 shares in the company, valued at $8,445,613.20. This represents a 14.78 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In the last 90 days, insiders sold 29,300 shares of company stock worth $3,002,989. Insiders own 2.10% of the company’s stock.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.